Insider Selling: Zynex, Inc. (NASDAQ:ZYXI) CFO Sells 10,000 Shares of Stock

Zynex, Inc. (NASDAQ:ZYXI) CFO Daniel J. Moorhead sold 10,000 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $7.15, for a total value of $71,500.00. Following the completion of the sale, the chief financial officer now directly owns 10,050 shares in the company, valued at approximately $71,857.50. The trade was a 49.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Zynex Stock Performance

NASDAQ ZYXI opened at $7.23 on Thursday. The firm has a market capitalization of $230.25 million, a P/E ratio of 48.20 and a beta of 0.81. The company has a debt-to-equity ratio of 1.66, a current ratio of 3.94 and a quick ratio of 3.15. Zynex, Inc. has a 1-year low of $7.01 and a 1-year high of $13.19. The business’s 50-day simple moving average is $7.79 and its 200-day simple moving average is $8.03.

Institutional Investors Weigh In On Zynex

Several hedge funds have recently modified their holdings of ZYXI. Hotchkis & Wiley Capital Management LLC raised its holdings in shares of Zynex by 24.7% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 746,380 shares of the company’s stock valued at $6,090,000 after buying an additional 147,770 shares during the period. GSA Capital Partners LLP grew its position in shares of Zynex by 72.7% in the 3rd quarter. GSA Capital Partners LLP now owns 79,930 shares of the company’s stock worth $652,000 after acquiring an additional 33,649 shares in the last quarter. Lido Advisors LLC acquired a new position in Zynex during the 4th quarter valued at approximately $240,000. Geode Capital Management LLC boosted its position in Zynex by 6.7% during the 3rd quarter. Geode Capital Management LLC now owns 425,509 shares of the company’s stock valued at $3,473,000 after purchasing an additional 26,774 shares during the period. Finally, Janney Montgomery Scott LLC boosted its position in Zynex by 22.3% during the 3rd quarter. Janney Montgomery Scott LLC now owns 144,439 shares of the company’s stock valued at $1,179,000 after purchasing an additional 26,368 shares during the period. 29.68% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and issued a $17.00 price target on shares of Zynex in a research note on Friday, December 6th.

About Zynex

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.